Dr BSc - Vivos Chief Officer
| RDGL Stock | USD 0.08 0 4.22% |
Insider
Dr BSc is Chief Officer of Vivos Inc
| Phone | 509 736 4000 |
| Web | https://www.radiogel.com |
Vivos Management Efficiency
The company has return on total asset (ROA) of (0.6206) % which means that it has lost $0.6206 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.174) %, meaning that it created substantial loss on money invested by shareholders. Vivos' management efficiency ratios could be used to measure how well Vivos manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Brad Lerman | Medtronic PLC | 63 | |
| Christian Klaussner | Siemens Healthineers AG | N/A | |
| Franois Houten | Koninklijke Philips NV | 64 | |
| Lori Winkler | Zimmer Biomet Holdings | 62 | |
| Paul Flynn | DexCom Inc | 55 | |
| Didier Deltort | Zimmer Biomet Holdings | 52 | |
| Shez Partovi | Koninklijke Philips NV | 54 | |
| Jereme Sylvain | DexCom Inc | 44 | |
| Andre Hartung | Siemens Healthineers AG | N/A | |
| Sally Saba | Medtronic PLC | N/A | |
| Carsten Bertram | Siemens Healthineers AG | N/A | |
| Randel Woodgrift | Abbott Laboratories | 59 | |
| Rachel Ellingson | Zimmer Biomet Holdings | 54 | |
| Elaine Leavenworth | Abbott Laboratories | 65 | |
| Louis Morrone | Abbott Laboratories | 44 | |
| Michel DVM | Siemens Healthineers AG | 62 | |
| Wilfred Zuilen | Zimmer Biomet Holdings | 54 | |
| Nitin MD | Zimmer Biomet Holdings | N/A | |
| Spencer Stiles | Stryker | 47 | |
| Sreelakshmi Kolli | Zimmer Biomet Holdings | 46 | |
| MSc MD | Medtronic PLC | N/A | |
Management Performance
| Return On Equity | -1.17 | |||
| Return On Asset | -0.62 |
Vivos Inc Leadership Team
Elected by the shareholders, the Vivos' board of directors comprises two types of representatives: Vivos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vivos. The board's role is to monitor Vivos' management team and ensure that shareholders' interests are well served. Vivos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vivos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Chief Officer | ||
| Michael Korenko, President CEO, Director | ||
| FuMin Su, Chief Officer | ||
| PE MS, Chief Mang | ||
| Carlton DDS, Independent Sec | ||
| Dr BSc, Chief Officer |
Vivos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Vivos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.17 | |||
| Return On Asset | -0.62 | |||
| Operating Margin | (67.68) % | |||
| Current Valuation | 15.27 M | |||
| Shares Outstanding | 359.89 M | |||
| Shares Owned By Insiders | 5.41 % | |||
| Price To Earning | 0.17 X | |||
| Price To Book | 9.01 X | |||
| Price To Sales | 598.62 X | |||
| Revenue | 14.89 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Vivos OTC Stock
Vivos financial ratios help investors to determine whether Vivos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vivos with respect to the benefits of owning Vivos security.